XMU-MP-1

N/A

Report date: 2022/01/05 15:24:33
NME

Base Information

Drug NameXMU-MP-1
Drug Alias NameXMU-MP-1
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase JAK3 inhibitorsGlycogen synthase kinase-3 beta inhibitors
TargetsMacrophage-stimulating protein receptor
Therapy Area/IndicationsChemical and Drug Induced Liver Injury
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesXiamen University
China Registration ClassN/A

Develop Information

Active CompaniesXiamen University
Inactive CompaniesN/A
Active IndicationsChemical and Drug Induced Liver Injury
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A